RecruitingPhase not listedNCT03998202
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
Sponsor: Wake Forest University Health Sciences
Chillicothe, OH · Columbus, OH · Findlay, OH · +144 more sites
Colorectal Cancer clinical trials in Columbus, OH
19 recruiting colorectal cancer studies with a site in Columbus, OH.
RecruitingPhase 1NCT06400472
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Sponsor: Eli Lilly and Company
Columbus, OH · +10 more sites
RecruitingPhase 1 / Phase 2NCT06710756
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Sponsor: Perspective Therapeutics
Cleveland, OH · Columbus, OH · +14 more sites
RecruitingPhase 2NCT05673148
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Sponsor: Alliance for Clinical Trials in Oncology
Centerville, OH · Cleveland, OH · +185 more sites
RecruitingPhase 1NCT07085091
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Sponsor: ALX Oncology Inc.
Columbus, OH · +11 more sites
RecruitingPhase 3NCT05863195
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
Sponsor: ECOG-ACRIN Cancer Research Group
Cleveland, OH · Columbus, OH · Youngstown, OH · +59 more sites
RecruitingPhase 2NCT05489211
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Sponsor: AstraZeneca
Cincinnati, OH · Columbus, OH · +16 more sites
RecruitingPhase 1 / Phase 2NCT05592626
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Sponsor: Marengo Therapeutics, Inc.
Columbus, OH · +12 more sites
RecruitingPhase 1NCT05433142
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Sponsor: Xencor, Inc.
Cincinnati, OH · Columbus, OH · +18 more sites
RecruitingPhase 1 / Phase 2NCT03526835
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Sponsor: Merus B.V.
Cleveland, OH · Columbus, OH · Maumee, OH · +28 more sites
RecruitingPhase 2NCT06948448
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
Sponsor: Ono Pharmaceutical Co., Ltd.
Columbus, OH · +10 more sites
RecruitingPhase 1 / Phase 2NCT06051695
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Sponsor: A2 Biotherapeutics Inc.
Columbus, OH · +11 more sites
RecruitingPhase 3NCT06950385
Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis
Sponsor: Rapamycin Holdings Inc.
Cleveland, OH · Columbus, OH · +16 more sites
RecruitingPhase 2NCT07407647
Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer
Sponsor: Ohio State University Comprehensive Cancer Center
Columbus, OH
RecruitingNot applicableNCT06746012
Designing a Dyad-Based mHealth Intervention to Improve Adherence to Lifestyle Recommendations in Colorectal Cancer Survivors and Their Family Caregivers
Sponsor: Ohio State University Comprehensive Cancer Center
Columbus, OH
RecruitingPhase 1 / Phase 2NCT06395519
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Sponsor: 858 Therapeutics, Inc.
Columbus, OH · +13 more sites
RecruitingNot applicableNCT06666192
The Ohio State University (OSU) SCREEN Community Program
Sponsor: Ohio State University Comprehensive Cancer Center
Columbus, OH
RecruitingPhase 1 / Phase 2NCT06682793
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Sponsor: A2 Biotherapeutics Inc.
Columbus, OH · +9 more sites
RecruitingPhase not listedNCT05234177
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Sponsor: Tempus AI
Canton, OH · Cincinnati, OH · Columbus, OH · +17 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.